Can two experimental pills work together safely? a trial seeks answers

NCT ID NCT07730567

Not yet recruiting Knowledge-focused Sponsor: Addpharma Inc. Source: ClinicalTrials.gov ↗

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This early-stage trial is testing two experimental oral drugs, AD-236A and AD-236B, in healthy adult volunteers. The goal is to see how the drugs interact when taken together and whether the combination is safe. The study involves 44 participants aged 19 to 55 and will measure drug levels in the blood over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: two experimental oral tablets called AD-236A and AD-236B, tested alone and together
What this could lead to: If safe and well-tolerated, this could support further development of these drugs for conditions like high cholesterol and type 2 diabetes.
What could go wrong: This is an early phase 1 trial in only 44 healthy adults, so results may not predict effects in patients. The drugs are experimental and may cause unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETE TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperlipidemia type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETE TYPE 2 HYPERLIPIDEMIA

Contacts and locations

Locations

H+ Yangji Hospital, Seoul,

Seoul, 08779, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.